Stability of the Antimalarial Drug Dihydroartemisinin under Physiologically Relevant Conditions: Implications for Clinical Treatment and Pharmacokinetic and In Vitro Assays

被引:42
作者
Parapini, Silvia [1 ]
Olliaro, Piero [2 ,3 ]
Navaratnam, Visweswaran [4 ,5 ]
Taramelli, Donatella [1 ]
Basilico, Nicoletta [6 ]
机构
[1] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy
[2] WHO, UNICEF UNDP World Bank WHO Special Programme Res, CH-1211 Geneva, Switzerland
[3] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England
[4] Univ Sains Malaysia, Ctr Drug Res, George Town, Malaysia
[5] Taylors Univ, Postgrad Res & Strateg Dev, Selangor, Malaysia
[6] Univ Milan, Dipartimento Sci Biomed Chirurg & Odontoiatr, Milan, Italy
关键词
METABOLITE DIHYDROARTEMISININ; ORAL ARTESUNATE; ARTEMISININ; IRON; ARTEMETHER; PARASITE; MALARIA; PLASMA;
D O I
10.1128/AAC.00183-15
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Artemisinins are peroxidic antimalarial drugs known to be very potent but highly chemically unstable; they degrade in the presence of ferrous iron, Fe(II)-heme, or biological reductants. Less documented is how this translates into chemical stability and antimalarial activity across a range of conditions applying to in vitro testing and clinical situations. Dihydroartemisinin (DHA) is studied here because it is an antimalarial drug on its own and the main metabolite of other artemisinins. The behaviors of DHA in phosphate-buffered saline, plasma, or erythrocyte lysate at different temperatures and pH ranges were examined. The antimalarial activity of the residual drug was evaluated using the chemosensitivity assay on Plasmodium falciparum, and the extent of decomposition of DHA was established through use of high-performance liquid chromatography with electrochemical detection analysis. The role of the Fe(II)-heme was investigated by blocking its reactivity using carbon monoxide (CO). A significant reduction in the antimalarial activity of DHA was seen after incubation in plasma and to a lesser extent in erythrocyte lysate. Activity was reduced by half after 3 h and almost completely abolished after 24 h. Serum-enriched media also affected DHA activity. Effects were temperature and pH dependent and paralleled the increased rate of decomposition of DHA from pH 7 upwards and in plasma. These results suggest that particular care should be taken in conducting and interpreting in vitro studies, prone as their results are to experimental and drug storage conditions. Disorders such as fever, hemolysis, or acidosis associated with malaria severity may contribute to artemisinin instability and reduce their clinical efficacy.
引用
收藏
页码:4046 / 4052
页数:7
相关论文
共 25 条
  • [1] A pharmacokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated falciparum malaria
    Batty, KT
    Thu, LTA
    Davis, TME
    Ilett, KF
    Mai, TX
    Hung, NC
    Tien, NP
    Powell, SM
    Thien, HV
    Binh, TQ
    Kim, NV
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 45 (02) : 123 - 129
  • [2] Synthesis and antiplasmodial activity of new heteroaryl derivatives of 7-chloro-4-aminoquinoline
    Casagrande, Manolo
    Barteselli, Anna
    Basilico, Nicoletta
    Parapini, Silvia
    Taramelli, Donatella
    Sparatore, Anna
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (19) : 5965 - 5979
  • [3] Interaction of Artemisinins with Oxyhemoglobin Hb-FeII, Hb-FeII, CarboxyHb-FeII, Heme-FeII, and Carboxyheme FeII: Significance for Mode of Action and Implications for Therapy of Cerebral Malaria
    Coghi, Paolo
    Basilico, Nicoletta
    Taramelli, Donatella
    Chan, Wing-Chi
    Haynes, Richard K.
    Monti, Diego
    [J]. CHEMMEDCHEM, 2009, 4 (12) : 2045 - 2053
  • [4] Stability of Peroxide Antimalarials in the Presence of Human Hemoglobin
    Creek, Darren J.
    Ryan, Eileen
    Charman, William N.
    Chiu, Francis C. K.
    Prankerd, Richard J.
    Vennerstrom, Jonathan L.
    Charman, Susan A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (08) : 3496 - 3500
  • [5] Kinetics of iron-mediated artemisinin degradation: Effect of solvent composition and iron salt
    Creek, DJ
    Chiu, FCK
    Prankerd, RJ
    Charman, SA
    Charman, WN
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 94 (08) : 1820 - 1829
  • [6] Artemisinin resistance is a clear and present danger
    Dondorp, Arjen M.
    Ringwald, Pascal
    [J]. TRENDS IN PARASITOLOGY, 2013, 29 (08) : 359 - 360
  • [7] Dihydroartemisinin inhibits the human erythroid cell differentiation by altering the cell cycle
    Finaurini, Sara
    Basilico, Nicoletta
    Corbett, Yolanda
    D'Alessandro, Sarah
    Parapini, Silvia
    Olliaro, Piero
    Haynes, Richard K.
    Taramelli, Donatella
    [J]. TOXICOLOGY, 2012, 300 (1-2) : 57 - 66
  • [8] A liquid chromatographic-tandem mass spectrometric method for determination of artemether and its metabolite dihydroartemisinin in human plasma
    Hanpithakpong, Warunee
    Kamanikom, Benjamas
    Singhasivanon, Pratap
    White, Nicholas J.
    Day, Nicholas P. J.
    Lindegardh, Niklas
    [J]. BIOANALYSIS, 2009, 1 (01) : 37 - 46
  • [9] Artesunate and Dihydroartemisinin (DHA): Unusual Decomposition Products Formed under Mild Conditions and Comments on the Fitness of DHA as an Antimalarial Drug
    Haynes, Richard K.
    Ho-Wai, Chan M.
    Lung, Chung-Man
    Ng, Nga-Chun
    Wong, Ho-Ning
    Shek, Lai Yung
    Williams, Ian D.
    Cartwright, Anthony
    Gomes, Melba F.
    [J]. CHEMMEDCHEM, 2007, 2 (10) : 1448 - 1463
  • [10] Reactions of Antimalarial Peroxides with Each of Leucomethylene Blue and Dihydroflavins: Flavin Reductase and the Cofactor Model Exemplified
    Haynes, Richard K.
    Cheu, Kwan-Wing
    Tang, Maggie Mei-Ki
    Chen, Min-Jiao
    Guo, Zu-Feng
    Guo, Zhi-Hong
    Coghi, Paolo
    Monti, Diego
    [J]. CHEMMEDCHEM, 2011, 6 (02) : 279 - 291